• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安慰剂镇痛的神经生物学:从内源性阿片类物质到胆囊收缩素

The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin.

作者信息

Benedetti F, Amanzio M

机构信息

Department of Neuroscience, University of Torino Medical School, Italy.

出版信息

Prog Neurobiol. 1997 Jun;52(2):109-25. doi: 10.1016/s0301-0082(97)00006-3.

DOI:10.1016/s0301-0082(97)00006-3
PMID:9185235
Abstract

Placebo is a widespread phenomenon in medicine and biology and its mechanisms are understood only partially. Most of our understanding of placebo comes from studies on pain. In particular, placebo analgesia represents a situation where the administration of a substance known to be non-analgesic produces an analgesic response when the subject is told that it is a pain killer. Several theories try to explain this effect by means of anxiety mechanisms, cognitive processes and classical conditioning. However, the placebo response is bidirectional, i.e. analgesic and algesic. In fact, if a subject is told that the ineffective substance is a hyperalgesic drug, a pain increase may occur. The negative effects of placebo are called nocebo and, in extreme cases, they lead to severe pathological conditions. The neurobiology of placebo was born when some authors discovered that placebo analgesia is mediated by endogenous opioids. This claim comes from the observation that the opioid antagonist naloxone can reverse placebo analgesia. On the basis of the discovery of the anti-opioid action of the neuropeptide cholecystokinin, recent studies demonstrate that the blockade of cholecystokinin receptors potentiates the placebo analgesic response, thus suggesting an inhibitory role of cholecystokinin in placebo analgesia. Thus, by antagonizing the anti-opioid action of cholecystokinin during a placebo procedure, a potentiation of the endogenous opioid systems can be obtained.

摘要

安慰剂是医学和生物学中一种普遍存在的现象,其机制仅得到部分理解。我们对安慰剂的大多数认识来自于对疼痛的研究。特别是,安慰剂镇痛是指当告知受试者某种已知无镇痛作用的物质是止痛药时,该物质的给药会产生镇痛反应的情况。有几种理论试图通过焦虑机制、认知过程和经典条件作用来解释这种效应。然而,安慰剂反应是双向的,即镇痛和致痛。事实上,如果告知受试者该无效物质是一种致痛药物,可能会出现疼痛加剧的情况。安慰剂的负面影响被称为反安慰剂效应,在极端情况下,会导致严重的病理状况。当一些作者发现安慰剂镇痛是由内源性阿片类物质介导时,安慰剂神经生物学应运而生。这一观点源于阿片类拮抗剂纳洛酮可以逆转安慰剂镇痛的观察结果。基于神经肽胆囊收缩素的抗阿片作用的发现,最近的研究表明,阻断胆囊收缩素受体可增强安慰剂镇痛反应,从而提示胆囊收缩素在安慰剂镇痛中起抑制作用。因此,在安慰剂过程中通过拮抗胆囊收缩素的抗阿片作用,可以增强内源性阿片系统的作用。

相似文献

1
The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin.安慰剂镇痛的神经生物学:从内源性阿片类物质到胆囊收缩素
Prog Neurobiol. 1997 Jun;52(2):109-25. doi: 10.1016/s0301-0082(97)00006-3.
2
The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.阿片类拮抗剂纳洛酮和胆囊收缩素拮抗剂丙谷胺对安慰剂镇痛的相反作用。
Pain. 1996 Mar;64(3):535-543. doi: 10.1016/0304-3959(95)00179-4.
3
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.痛觉过敏的反安慰剂效应的生化和神经内分泌基础。
J Neurosci. 2006 Nov 15;26(46):12014-22. doi: 10.1523/JNEUROSCI.2947-06.2006.
4
Nocebo hyperalgesia: how anxiety is turned into pain.反安慰剂高敏反应:焦虑如何转化为疼痛。
Curr Opin Anaesthesiol. 2007 Oct;20(5):435-9. doi: 10.1097/ACO.0b013e3282b972fb.
5
Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide.胆囊收缩素拮抗剂丙谷胺对安慰剂性痛觉过敏的阻断作用。
Pain. 1997 Jun;71(2):135-40. doi: 10.1016/s0304-3959(97)03346-0.
6
Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms.肠易激综合征(IBS)患者随着时间推移安慰剂镇痛作用增强与欲望和期望有关,而非内源性阿片类机制。
Pain. 2005 Jun;115(3):338-347. doi: 10.1016/j.pain.2005.03.014.
7
Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems.在小鼠中对安慰剂镇痛进行剖析:激活阿片类和非阿片类系统的条件。
J Psychopharmacol. 2010 Oct;24(10):1561-7. doi: 10.1177/0269881109104848. Epub 2009 Apr 24.
8
Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect.信念还是需求?解释安慰剂效应神经化学中的个体差异。
Brain Behav Immun. 2006 Jan;20(1):15-26. doi: 10.1016/j.bbi.2005.08.006. Epub 2005 Oct 20.
9
Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors.胆囊收缩素受体 2 型激活破坏阿片类药物诱导的安慰剂反应。
Psychopharmacology (Berl). 2011 Feb;213(4):791-7. doi: 10.1007/s00213-010-2037-y. Epub 2010 Oct 8.
10
[Mechanisms of endogenous pain modulation illustrated by placebo analgesia : functional imaging findings].[安慰剂镇痛所阐明的内源性疼痛调制机制:功能成像研究结果]
Schmerz. 2010 Apr;24(2):122-9. doi: 10.1007/s00482-010-0901-7.

引用本文的文献

1
Investigating the Influence of Experimentally Induced Secondary Hyperalgesia on Pain Prediction Error Encoding in Healthy Individuals: A Novel Virtual Reality Protocol.探究实验性诱导的继发性痛觉过敏对健康个体疼痛预测误差编码的影响:一种新型虚拟现实方案。
Eur J Pain. 2025 Oct;29(9):e70113. doi: 10.1002/ejp.70113.
2
Perceiving immunity, predicting somatic symptoms: Validation of the 'Perceived Immunity' scale and its association with daily health.感知免疫力,预测躯体症状:“感知免疫力”量表的验证及其与日常健康的关联
Br J Health Psychol. 2025 Feb;30(1):e12772. doi: 10.1111/bjhp.12772.
3
Learning pain from others: a systematic review and meta-analysis of studies on placebo hypoalgesia and nocebo hyperalgesia induced by observational learning.
从他人处学习疼痛:基于观察学习所致安慰剂镇痛和反安慰剂痛觉过敏的研究的系统评价和荟萃分析。
Pain. 2023 Nov 1;164(11):2383-2396. doi: 10.1097/j.pain.0000000000002943. Epub 2023 Jun 15.
4
Harnessing the placebo effect to enhance emotion regulation effectiveness and choice.利用安慰剂效应增强情绪调节的效果和选择。
Sci Rep. 2023 Feb 9;13(1):2373. doi: 10.1038/s41598-023-29045-6.
5
The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review.条件性开放标签安慰剂在阿片类药物剂量减少中的应用:病例报告及文献综述
Front Pain Res (Lausanne). 2021 Jul 12;2:697475. doi: 10.3389/fpain.2021.697475. eCollection 2021.
6
Methods for assessing cough sensitivity.评估咳嗽敏感性的方法。
J Thorac Dis. 2020 Sep;12(9):5224-5237. doi: 10.21037/jtd-2020-icc-005.
7
Personality Differences of Brain Networks in Placebo Analgesia and Nocebo Hyperalgesia: A Psychophysiological Interaction (PPI) Approach in fMRI.在安慰剂镇痛和反安慰剂痛觉过敏中的大脑网络的人格差异:功能磁共振成像中的心理生理交互(PPI)方法。
Neural Plast. 2020 Oct 19;2020:8820443. doi: 10.1155/2020/8820443. eCollection 2020.
8
Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control.条件性开放标签安慰剂:一种用于减少阿片类药物剂量和控制疼痛的先导性药物行为方法。
Pain Rep. 2020 Jul 20;5(4):e828. doi: 10.1097/PR9.0000000000000828. eCollection 2020 Jul-Aug.
9
Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?根治性切除直肠癌的辅助化疗:数据的有效性如何?
World J Gastrointest Oncol. 2020 Apr 15;12(4):503-513. doi: 10.4251/wjgo.v12.i4.503.
10
Validity of studies suggesting preoperative chemotherapy for resectable thoracic esophageal cancer: A critical appraisal of randomized trials.提示可切除胸段食管癌术前化疗的研究的有效性:对随机试验的批判性评价
World J Gastrointest Oncol. 2020 Jan 15;12(1):113-123. doi: 10.4251/wjgo.v12.i1.113.